Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Pain
|
August 18, 2009
Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment
Carmen Walter, Jörn Lötsch
Clinical Pharmacokinetics
|
September 12, 2009
Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?
Carmen Walter, Lisa Felden, Jörn Lötsch
Schmerz (Berlin, Germany)
|
September 4, 2019
[Generating knowledge from complex data sets in human experimental pain research]
Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Clinical Pharmacokinetics
|
January 1, 2016
Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations
Carmen Walter, Claudia Knothe, Jörn Lötsch
Schmerz (Berlin, Germany)
|
April 25, 2020
[Pain models and clinical pain research are not contradictory]
Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Pharmacogenomics
|
November 19, 2013
µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain
Carmen Walter, Alexandra Doehring, Bruno G Oertel, et al.
Frontiers in Human Neuroscience
|
December 21, 2020
Application of Referencing Techniques in EEG-Based Recordings of Contact Heat Evoked Potentials (CHEPS)
Malte Anders, Björn Anders, Matthias Kreuzer, et al.
Journal of Clinical Psychopharmacology
|
August 1, 2013
Exogenous delta⁹-tetrahydrocannabinol influences circulating endogenous cannabinoids in humans
Carmen Walter, Nerea Ferreirós, Philipp Bishay, et al.
Drug Discovery Today
|
July 11, 2015
Olfactory drug effects approached from human-derived data
Jörn Lötsch, Claudia Knothe, Catharina Lippmann, et al.
Clinical Pharmacokinetics
|
October 27, 2012
Pharmacokinetics of non-intravenous formulations of fentanyl
Jörn Lötsch, Carmen Walter, Michael J Parnham, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Pain
|
August 18, 2009
Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment
Carmen Walter, Jörn Lötsch
Clinical Pharmacokinetics
|
September 12, 2009
Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?
Carmen Walter, Lisa Felden, Jörn Lötsch
Schmerz (Berlin, Germany)
|
September 4, 2019
[Generating knowledge from complex data sets in human experimental pain research]
Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Clinical Pharmacokinetics
|
January 1, 2016
Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations
Carmen Walter, Claudia Knothe, Jörn Lötsch
Schmerz (Berlin, Germany)
|
April 25, 2020
[Pain models and clinical pain research are not contradictory]
Jörn Lötsch, Gerd Geisslinger, Carmen Walter
Pharmacogenomics
|
November 19, 2013
µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain
Carmen Walter, Alexandra Doehring, Bruno G Oertel, et al.
Frontiers in Human Neuroscience
|
December 21, 2020
Application of Referencing Techniques in EEG-Based Recordings of Contact Heat Evoked Potentials (CHEPS)
Malte Anders, Björn Anders, Matthias Kreuzer, et al.
Journal of Clinical Psychopharmacology
|
August 1, 2013
Exogenous delta⁹-tetrahydrocannabinol influences circulating endogenous cannabinoids in humans
Carmen Walter, Nerea Ferreirós, Philipp Bishay, et al.
Drug Discovery Today
|
July 11, 2015
Olfactory drug effects approached from human-derived data
Jörn Lötsch, Claudia Knothe, Catharina Lippmann, et al.
Clinical Pharmacokinetics
|
October 27, 2012
Pharmacokinetics of non-intravenous formulations of fentanyl
Jörn Lötsch, Carmen Walter, Michael J Parnham, et al.
Page
of 4